DSM acquires cosmetic active ingredient specialist Pentapharm

06-Jul-2007

Royal DSM N.V. announced that privately owned Pentapharm Holding Ltd. and DSM nutritional products Ltd. have signed an agreement on the sale and purchase of 100% of the Pentapharm's shares to DSM. Pentapharm, headquartered in Basel (Switzerland) with sales revenues of some EUR 40 million, employs about 200 people at locations in Switzerland, Japan and Brazil. Pentapharm develops and produces active ingredients and system solutions for the cosmetics industry and is also present in niche pharmaceutical and diagnostics markets.

According to the company, with the acquisition of Pentapharm, DSM Nutritional Products will further strengthen its position as the global leading supplier of active ingredients for Skin and Sun Care. The parties have agreed not to disclose financial details of the transaction.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!